Radiotherapy market covers external beam radiotherapy and internal beam radiotherapy applications for various cancers. In 2016, prostate segment held largest share in both segments. Growing incidence of prostate cancer & high success rates achieved with external beam radiation are major factors driving the growth of this market segment.
The global radiotherapy market expected to reach USD 9.47 billion by 2022 from USD 6.81 billion in 2017, at a CAGR of 6.8%. Rapidly increasing geriatric population, growing incidence of cancer cases across globe, increasing symposiums driving investments in radiotherapy, & rising demand for radiotherapy devices and procedures globally are some of key factors driving growth.
Complete report on Radiotherapy Market spread across 222 Pages, Profiling 15 Companies and Supported with 116 Tables and 36 Figures is now available at http://www.reportsnreports.com/reports/172707-radiotherapy-devices-market-by-technology-applications-products-2011-2016.html .
Global radiotherapy market report analyzes by type, product type, application, end user, & region. Based on type, external beam radiotherapy segment accounted for largest share in 2016. Growing adoption of this therapy in emerging markets & development of advanced external beam radiotherapy devices to localize tumorous cells while minimizing harm to surrounding healthy cells are some of major factors contributing to growth of this market segment.
Stakeholders Covered in Radiotherapy Market Report as Follows
- Radiotherapy System and Product Manufacturers, Suppliers, and Software Providers
- Radiotherapy Product Distributors
- Medical Research Laboratories
- Cancer Research Organizations
- Academic Medical Centers and Universities
- Business Research and Consulting Service Providers
In radiotherapy market report electron-emitting high-energy linear accelerators segment expected to account for largest share of external beam radiotherapy market in 2016. Development of advanced linear accelerators and growing adoption of these devices are some of factors driving growth of this market. High growth in this segment can be attributed to growing number of new cancer cases, improvements in healthcare facilities, growing medical tourism, & focus of global players on emerging nations in Asia-Pacific such as China and India.
Interested in this New Research Study the Sample Copy of this research is Available Now http://www.reportsnreports.com/contacts/requestsample.aspx?name=172707 .
The radiotherapy market covers external beam radiotherapy and internal beam radiotherapy applications for various cancers. In 2016, the prostate segment held the largest share in both the segments. The growing incidence of prostate cancer and high success rates achieved with external beam radiation are the major factors driving the growth of this market segment. This report studies the radiotherapy market based on product type, type, application, and end user.
Breakdown of supply-side primary interviews: by company type, designation, and region:
- By Company Type – Tier 1 –20%, Tier 2 –38% and Tier 3 –42%
- By Designation – C-level – 15%, Director level – 24%, Others – 61%
- By Region – North America – 34%, Europe – 26%, APAC – 23%, RoW – 17%
Some of major players in radiotherapy market are Varian Medical Systems, Inc. (U.S.), Elekta AB (Sweden), Accuray Incorporated (U.S.), Ion Beam Applications (IBA) (Belgium), Nordion, Inc. (Canada), C. R. Bard, Inc. (U.S.), Isoray Medical, Inc. (U.S.), RaySearch Laboratories (Sweden), Mevion Medical Systems, Inc. (U.S.), and Mitsubishi Electric Corporation (Japan).
Click now for more Details, Queries, Other Information and Discount on this study “Radiotherapy Market by Type (External (IGRT, IMRT, 3D-CRT), Internal (LDR, HDR) & Systemic), Product (Proton Beam, Cyberknife, LINAC, Seed, Samarium), Application (Prostate, Breast, Cervical), End User, and Region – Global Forecasts to 2022” report @ http://www.reportsnreports.com/contacts/discount.aspx?name=172707 .
Report covers radiotherapy market across four major geographies, namely, North America, Europe, Asia-Pacific, & Rest of the World (RoW). North America accounted for largest share of global radiotherapy market in 2016, followed by Europe. Large share of North American region mainly attributed to increasing healthcare expenditure in region, technological advancements, & high adoption of radiotherapy products owing to increasing incidence of cancer.
Asia-Pacific is expected to register highest growth rate during forecast period. Factors such as rapidly increasing aging population, growing focus of players on emerging markets, improvements in healthcare infrastructure, and rising number of new cancer cases in this region are driving the growth of the radiotherapy market in the Asia-Pacific.